Aura Biosciences, Inc.
AURA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501796
No open-market purchases or sales by Aura Biosciences, Inc. insiders were filed in the last 90 days; 146 institutions reported holding it in 13F filings for Q2 2026, worth $677.2M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Aura Biosciences, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- −1 vs. Q2 2022
- Shares held
- 16.3M
- +523.3K (+3.3%) vs. Q2 2022
- Total value
- $295.7M
- +$71.9M (+32.1%) vs. Q2 2022
- New holders
- 2
- 24 more added
- Sold out
- 3
- 9 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AURA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 146 | $677.2M |
| Q1 2026 | 126 | $340.3M |
| Q4 2025 | 117 | $273.8M |
| Q3 2025 | 106 | $319.2M |
| Q2 2025 | 105 | $316.9M |
| Q1 2025 | 94 | $231.5M |
| Q4 2024 | 94 | $324.3M |
| Q3 2024 | 81 | $329.2M |
| Q2 2024 | 75 | $300.4M |
| Q1 2024 | 78 | $307.1M |
| Q4 2023 | 72 | $327.8M |
| Q3 2023 | 64 | $254.4M |
| Q2 2023 | 59 | $334.4M |
| Q1 2023 | 57 | $232.6M |
| Q4 2022 | 49 | $250.0M |
| Q3 2022 | 43 | $295.7M |
| Q2 2022 | 44 | $223.8M |
| Q1 2022 | 34 | $298.8M |
| Q4 2021 | 32 | $220.1M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Aura Biosciences, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Matrix Capital Management Company, LP | 4,112,870 | $74.5M | 1.43% | 00.0% | Unchanged |
| Medicxi Ventures Management (Jersey) Ltd | 3,039,892 | $55.1M | 22.93% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,312,318 | $41.9M | 0.05% | +1590.0% | Added |
| Adage Capital Partners GP, L.L.C. | 1,451,201 | $26.3M | 0.07% | +174,582+13.7% | Added |
| Rock Springs Capital Management LP | 1,015,757 | $18.4M | 0.48% | +6,943+0.7% | Added |
| BlackRock Inc. | 1,013,455 | $18.4M | 0.00% | +126,732+14.3% | Added |
| Vanguard Group Inc | 605,884 | $11.0M | 0.00% | +170,709+39.2% | Added |
| FMR LLC | 603,761 | $10.9M | 0.00% | +2900.0% | Added |
| Nantahala Capital Management, LLC | 383,764 | $6.95M | 0.68% | +40,549+11.8% | Added |
| State Street Corp | 298,438 | $5.41M | 0.00% | +41,692+16.2% | Added |
| Geode Capital Management, LLC | 289,312 | $5.24M | 0.00% | +82,018+39.6% | Added |
| Regency Capital Management Inc. | 224,554 | $4.07M | 4.99% | −30,068−11.8% | Reduced |
| Decheng Capital Management III (Cayman), LLC | 210,000 | $3.81M | 1.38% | 00.0% | Unchanged |
| Citigroup Inc | 149,740 | $2.71M | 0.00% | +26,552+21.6% | Added |
| Northern Trust Corp | 145,101 | $2.63M | 0.00% | +12,409+9.4% | Added |
| Nuveen Asset Management, LLC | 61,724 | $1.12M | 0.00% | +497+0.8% | Added |
| Morgan Stanley | 55,152 | $1.00M | 0.00% | +613+1.1% | Added |
| Bank of New York Mellon Corp | 50,336 | $912.0K | 0.00% | +10,240+25.5% | Added |
| Charles Schwab Investment Management Inc | 47,003 | $852.0K | 0.00% | +3,994+9.3% | Added |
| Bank of America Corp | 45,239 | $820.0K | 0.00% | +9,896+28.0% | Added |
| Barclays PLC | 42,044 | $762.0K | 0.00% | −142−0.3% | Reduced |
| Rhumbline Advisers | 22,339 | $405.0K | 0.00% | +1,626+7.9% | Added |
| New York State Common Retirement Fund | 14,472 | $262.0K | 0.00% | +120+0.8% | Added |
| Captrust Financial Advisors | 13,414 | $243.0K | 0.00% | 00.0% | Unchanged |
| UBS Oconnor LLC | 12,430 | $225.0K | 0.00% | −78,109−86.3% | Reduced |
| UBS Group AG | 12,267 | $222.0K | 0.00% | −4,053−24.8% | Reduced |
| Dynamic Technology Lab Private Ltd | 11,961 | $217.0K | 0.02% | +11,961 | New |
| MetLife Investment Management | 11,026 | $199.8K | 0.00% | 00.0% | Unchanged |
| Water Island Capital LLC | 10,700 | $194.0K | 0.01% | −3,841−26.4% | Reduced |
| JPMorgan Chase & Co | 10,013 | $181.0K | 0.00% | +215+2.2% | Added |
| American International Group, Inc. | 8,700 | $158.0K | 0.00% | +123+1.4% | Added |
| Deutsche Bank AG | 8,035 | $146.0K | 0.00% | −1,226−13.2% | Reduced |
| California State Teachers Retirement System | 7,233 | $131.0K | 0.00% | −603−7.7% | Reduced |
| BNP Paribas Arbitrage, SA | 5,821 | $105.5K | 0.00% | +5,821 | New |
| Amalgamated Bank | 2,941 | $53.0K | 0.00% | +45+1.6% | Added |
| Legal & General Group Plc | 2,256 | $41.0K | 0.00% | +1,394+161.7% | Added |
| Ameritas Investment Partners, Inc. | 1,374 | $24.0K | 0.00% | 00.0% | Unchanged |
| Metropolitan Life Insurance Co | 1,280 | $23.2K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,262 | $23.0K | 0.00% | −2,687−68.0% | Reduced |
| STRS Ohio | 1,300 | $23.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 310 | $6.00K | 0.00% | −120−27.9% | Reduced |
| Royal Bank of Canada | 223 | $4.00K | 0.00% | +120+116.5% | Added |
| Credit Suisse AG | 103 | $2.00K | 0.00% | +91+758.3% | Added |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −61,575−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −22,917−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −750−100.0% | Sold out |